세계의 항문질환 치료 시장 보고서(2025년)

Anorectal disorder treatment involves addressing a set of medical conditions that impact the anal and rectal areas, leading to the development of anorectal disorders. The nature and severity of these disorders may vary depending on the specific condition.

The primary approaches to anorectal disorder treatment include medications, surgical procedures, and other therapeutic methods. Medications are substances employed for diagnosing, managing, preventing, or alleviating a range of medical conditions and ailments. These conditions encompass diarrhea, hemorrhoids, abscesses, fistulas, itching, among others. Medications can be administered through oral, parenteral, rectal, or other routes. These treatment modalities are utilized by diverse end-users, including hospitals, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The anorectal disorders treatment market research report is one of a series of new reports from The Business Research Company that provides anorectal disorders treatment market statistics, including anorectal disorders treatment industry global market size, regional shares, competitors with anorectal disorders treatment market share, detailed anorectal disorders treatment market segments, market trends and opportunities and any further data you may need to thrive in the anorectal disorders treatment industry. This anorectal disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anorectal disorders treatment market size has grown strongly in recent years. It will grow from $4.2 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging population, lifestyle factors, increased awareness, on-surgical interventions.

The anorectal disorders treatment market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to demand for patient education, changing dietary habits, demand for telemedicine, research and development activities. Major trends in the forecast period include technological advancements, endoscopy and imaging, public health initiatives.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. colorectal care by inflating prices of hemorrhoidal artery ligation devices and anal fistula plugs developed in Japan and France, resulting in delayed interventions and higher proctology surgical costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing elderly population is anticipated to drive the expansion of the anorectal disorder treatment market in the foreseeable future. This demographic constitutes older adults, typically defined as individuals aged 65 or above. Anorectal disorder treatment plays a crucial role in offering pain relief, improving hygiene, preventing recurrence, and enhancing the overall quality of life for the elderly population afflicted with anorectal disorders. For instance, in October 2022, the World Health Organization, a specialized health agency based in the US, reported that globally, one out of every six individuals would be 60 years or older by 2030, and this number is projected to reach 2.1 billion elderly people by 2050. Consequently, the escalating geriatric population is a significant driver behind the growth of the anorectal disorder treatment market.

The surge in colorectal cancer cases is projected to drive the growth of the anorectal disorder treatment market in the foreseeable future. Colorectal cancer, a malignancy originating in the colon or rectum, is the focal point of anorectal disorder treatment. This treatment aims to alleviate symptoms like pain, fistulas, and bowel irregularities resulting from the cancer or its treatment, ultimately enhancing patient comfort and quality of life. For instance, as of May 2023, the American Society of Clinical Oncology, a reputable US-based professional organization, estimates that approximately 153,020 adults in the US will receive a colorectal cancer diagnosis. This figure includes 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer. Consequently, the escalating incidence of colorectal cancer is a driving force behind the expansion of the anorectal disorder treatment market.

Prominent companies in the anorectal disorder treatment market are introducing novel medications and securing approvals to strengthen their market presence. This surge in drug development is broadening the spectrum of treatment options available for anorectal disorders, offering patients more precise and efficacious treatment choices, exemplified by the introduction of Budesonide 2mg Rectal Foam. For instance, in April 2023, Padagis US LLC, a reputable US-based pharmaceutical manufacturer, unveiled Budesonide 2mg Rectal Foam (a generic version of Uceris), an FDA-approved treatment for anorectal disorders. Uceris is a prescription corticosteroid medication utilized to manage active, mild-to-moderate cases of ulcerative colitis, an inflammatory bowel disease (IBD) that primarily affects the rectum and extends from the rectum to the sigmoid colon.

In June 2023, Merck and Co. Inc., a prominent US-based pharmaceutical company, completed the acquisition of Prometheus Biosciences Inc. for a sum of $10.8 billion. This strategic move is set to fortify Merck's immunology pipeline and bolster its presence in the field of immune-mediated diseases. Prometheus Biosciences Inc. is a distinguished biotechnology company based in the US, specializing in the development of products and treatments for inflammatory bowel disease, which encompasses anorectal disorders.

Major companies operating in the anorectal disorders treatment market are Cardinal Health Inc., Cigna Corporation., Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, AstraZeneca PLC, Merck and Co. Inc., Abbott Laboratories, GlaxoSmithKline PLC, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, McKesson Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., B. Braun Melsungen AG, Bausch Health Companies Inc., Olympus Corporation, Sun Pharmaceutical Industries Ltd., Ethicon Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical Inc., ConvaTec Group PLC, Lupin Limited, Akorn Inc., NATCO Pharma Limited.

North America was the largest region in the anorectal disorders treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in anorectal disorders treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anorectal disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anorectal disorders treatment market consists of revenues earned by entities by providing medical consultation, diagnostic tests and surgeries. The market value includes the value of related goods sold by the service provider or included within the service offering. The anorectal disorder treatment market also consists of sales of topical creams and ointments, wipes and cleansers and pads. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anorectal Disorders Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anorectal disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anorectal disorders treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anorectal disorders treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Drugs; Surgery; Other Treatment
• 2) By Disease: Diarrhea; Hemorrhoid; Abscesse; Fistula; Itching; Other Disease
• 3) By Route Of Administration: Oral; Parenteral; Rectal; Other Route of administration
• 4) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Drugs: Topical Agents; Oral Medications; Rectal Suppositories
• 2) By Surgery: Hemorrhoidectomy; Fistulotomy; Sphincterotomy; Other Surgical Procedures
• 3) By Other Treatment: Lifestyle Modifications; Dietary Changes; Physical Therapy; Minimally Invasive Procedures
• Companies Mentioned: Cardinal Health Inc.; Cigna Corporation.; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; AstraZeneca Plc; Merck and Co. Inc.; Abbott Laboratories; GlaxoSmithKline Plc; Medtronic Plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; McKesson Corporation; Teva Pharmaceutical Industries Ltd.; Boston Scientific Corporation; Mylan N.V.; B. Braun Melsungen AG; Bausch Health Companies Inc.; Olympus Corporation; Sun Pharmaceutical Industries Ltd.; Ethicon Inc.; Coloplast A/S; Teleflex Incorporated; Cook Medical Inc.; ConvaTec Group PLC; Lupin Limited; Akorn Inc.; NATCO Pharma Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anorectal Disorders Treatment Market Characteristics

3. Anorectal Disorders Treatment Market Trends And Strategies

4. Anorectal Disorders Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Anorectal Disorders Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anorectal Disorders Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anorectal Disorders Treatment Market Growth Rate Analysis
• 5.4. Global Anorectal Disorders Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anorectal Disorders Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anorectal Disorders Treatment Total Addressable Market (TAM)

6. Anorectal Disorders Treatment Market Segmentation

• 6.1. Global Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Surgery
• Other Treatment
• 6.2. Global Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diarrhea
• Hemorrhoid
• Abscesse
• Fistula
• Itching
• Other Disease
• 6.3. Global Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Rectal
• Other Route of administration
• 6.4. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of End-Users, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.5. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Agents
• Oral Medications
• Rectal Suppositories
• 6.6. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemorrhoidectomy
• Fistulotomy
• Sphincterotomy
• Other Surgical Procedures
• 6.7. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Other Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifestyle Modifications
• Dietary Changes
• Physical Therapy
• Minimally Invasive Procedures

7. Anorectal Disorders Treatment Market Regional And Country Analysis

• 7.1. Global Anorectal Disorders Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anorectal Disorders Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anorectal Disorders Treatment Market

• 8.1. Asia-Pacific Anorectal Disorders Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anorectal Disorders Treatment Market

• 9.1. China Anorectal Disorders Treatment Market Overview
• 9.2. China Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anorectal Disorders Treatment Market

• 10.1. India Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anorectal Disorders Treatment Market

• 11.1. Japan Anorectal Disorders Treatment Market Overview
• 11.2. Japan Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anorectal Disorders Treatment Market

• 12.1. Australia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anorectal Disorders Treatment Market

• 13.1. Indonesia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anorectal Disorders Treatment Market

• 14.1. South Korea Anorectal Disorders Treatment Market Overview
• 14.2. South Korea Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anorectal Disorders Treatment Market

• 15.1. Western Europe Anorectal Disorders Treatment Market Overview
• 15.2. Western Europe Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anorectal Disorders Treatment Market

• 16.1. UK Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anorectal Disorders Treatment Market

• 17.1. Germany Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anorectal Disorders Treatment Market

• 18.1. France Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anorectal Disorders Treatment Market

• 19.1. Italy Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anorectal Disorders Treatment Market

• 20.1. Spain Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anorectal Disorders Treatment Market

• 21.1. Eastern Europe Anorectal Disorders Treatment Market Overview
• 21.2. Eastern Europe Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anorectal Disorders Treatment Market

• 22.1. Russia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anorectal Disorders Treatment Market

• 23.1. North America Anorectal Disorders Treatment Market Overview
• 23.2. North America Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anorectal Disorders Treatment Market

• 24.1. USA Anorectal Disorders Treatment Market Overview
• 24.2. USA Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anorectal Disorders Treatment Market

• 25.1. Canada Anorectal Disorders Treatment Market Overview
• 25.2. Canada Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anorectal Disorders Treatment Market

• 26.1. South America Anorectal Disorders Treatment Market Overview
• 26.2. South America Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anorectal Disorders Treatment Market

• 27.1. Brazil Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anorectal Disorders Treatment Market

• 28.1. Middle East Anorectal Disorders Treatment Market Overview
• 28.2. Middle East Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anorectal Disorders Treatment Market

• 29.1. Africa Anorectal Disorders Treatment Market Overview
• 29.2. Africa Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anorectal Disorders Treatment Market Competitive Landscape And Company Profiles

• 30.1. Anorectal Disorders Treatment Market Competitive Landscape
• 30.2. Anorectal Disorders Treatment Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cigna Corporation. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anorectal Disorders Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca Plc
• 31.3. Merck and Co. Inc.
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline Plc
• 31.6. Medtronic Plc
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. McKesson Corporation
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Boston Scientific Corporation
• 31.12. Mylan N.V.
• 31.13. B. Braun Melsungen AG
• 31.14. Bausch Health Companies Inc.
• 31.15. Olympus Corporation

32. Global Anorectal Disorders Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anorectal Disorders Treatment Market

34. Recent Developments In The Anorectal Disorders Treatment Market

35. Anorectal Disorders Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Anorectal Disorders Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anorectal Disorders Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anorectal Disorders Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer